Mehta Kishan 4

What Happened
Mehta Kishan, a director of Biohaven Ltd. (BHVN), was granted a derivative award on April 28, 2026 covering 68,693 shares (reported as an award/grant, code "A"). The Form 4 lists the per-share amount as $0.00 and shows the reported value as $0 (derivative security). The filing indicates these are stock option shares that will vest in full on the earlier of April 28, 2027 or the date of the 2027 Annual Meeting, subject to Kishan’s continuous service.

Key Details

• Transaction date: 2026-04-28; Form 4 filed 2026-04-30 (timely filing).
• Transaction type: Award/Grant of a derivative (stock option) covering 68,693 shares; reported price $0.00.
• Vesting: Vests in full on earlier of April 28, 2027 or the 2027 Annual Meeting, subject to continuous service (per footnote).
• Shares owned after transaction: Not specified in the provided filing details.
• Filing timeliness: Filed within the standard Form 4 reporting window (appears timely).

Context
This was a director compensation grant (stock option award), not an open-market purchase or sale. Such awards are common for board compensation and do not by themselves indicate the insider is buying or selling stock in the market. The reported $0.00 on the line reflects how the derivative award was reported; the exercise price or potential future value is not provided in the summarized data.